Vascular Pathways, based in Naples, FL, manufactures wire-guided peripheral intravenous (PIV) catheter technology. Its flagship product, the AccuCath™ Intravenous Catheter System, was developed by founder Dr. Amir Belson and uses guidewire PIV technology for atraumatic vessel access and catheter deployment. The device is intended to reduce complication rates, increase first-attempt success rates, lower costs for healthcare providers, and improve patient satisfaction. The company is led by President and CEO Bill Bold. Vascular Pathways is backed by CHL Medical Partners, Ascension Health Ventures, and MVM Life Sciences. It has secured financing to support commercialization of the AccuCath system. Vascular Pathways is a Los Altos, Calif.-based medical device company focused on improving peripheral intravenous access. Its core product is the Rapid Intravascular Start (RIVS) IV catheter, which has received U.S. Food and Drug Administration clearance. The company plans to use new capital to commercialize the RIVS catheter in the U.S. Vascular Pathways was founded by Amir Belson, M.D. In conjunction with the financing, executives from investor firms joined the company's board of directors. The financing is intended to support scaling of commercialization efforts for the RIVS product.

Total raised

$19M

Funding rounds

2

Latest round

Debt Financing

Latest activity

Jun 2014